The Safety and Efficacy of an Oral Penicillin Challenge Program in Cancer Patients: A Multicenter Pilot Study

Abstract Antibiotic allergies are reported by up to 1 in 4 cancer patients, almost 50% of which are considered low risk and precede the cancer diagnosis. We demonstrate the successful and safe implementation of a pilot oral penicillin challenge program for cancer patients with low-risk penicillin allergies, increasing the use of penicillin and narrow-spectrum beta-lactams post-testing.

[1]  E. Phillips,et al.  Pathways to improved antibiotic allergy and antimicrobial stewardship practice: The validation of a beta-lactam antibiotic allergy assessment tool. , 2019, The journal of allergy and clinical immunology. In practice.

[2]  E. Jerschow,et al.  Safety and Outcomes of Oral Graded Challenges to Amoxicillin without Prior Skin Testing. , 2019, The journal of allergy and clinical immunology. In practice.

[3]  R. Walensky,et al.  Risk of meticillin resistant Staphylococcus aureus and Clostridium difficile in patients with a documented penicillin allergy: population based matched cohort study , 2018, British Medical Journal.

[4]  K. Huang,et al.  The Impact of Reported Beta-Lactam Allergy in Hospitalized Patients With Hematologic Malignancies Requiring Antibiotics , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  E. Phillips,et al.  Impact of an Integrated Antibiotic Allergy Testing Program on Antimicrobial Stewardship: A Multicenter Evaluation , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  A. Hershko,et al.  Oral Challenge without Skin Testing Safely Excludes Clinically Significant Delayed-Onset Penicillin Hypersensitivity. , 2017, The journal of allergy and clinical immunology. In practice.

[7]  Nanda Ramchandar,et al.  Amoxicillin challenge without penicillin skin testing in evaluation of penicillin allergy in a cohort of Marine recruits. , 2017, The journal of allergy and clinical immunology. In practice.

[8]  E. Phillips,et al.  Return to sender: the need to re‐address patient antibiotic allergy labels in Australia and New Zealand , 2016, Internal medicine journal.

[9]  D. MacFadden,et al.  Impact of Reported Beta-Lactam Allergy on Inpatient Outcomes: A Multicenter Prospective Cohort Study. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  M. Ben-Shoshan,et al.  Assessing the Diagnostic Properties of a Graded Oral Provocation Challenge for the Diagnosis of Immediate and Nonimmediate Reactions to Amoxicillin in Children. , 2016, JAMA pediatrics.

[11]  P. Polgreen,et al.  Improving Antimicrobial Stewardship by Antibiotic Allergy Delabeling: Evaluation of Knowledge, Attitude, and Practices Throughout the Emerging Infections Network , 2016, Open forum infectious diseases.

[12]  J. Trubiano,et al.  Old but not forgotten: Antibiotic allergies in General Medicine (the AGM Study) , 2016, The Medical journal of Australia.

[13]  A. Romano,et al.  Cross-Reactivity among Beta-Lactams , 2016, Current Allergy and Asthma Reports.

[14]  M. Chu,et al.  The impact of antimicrobial allergy labels on antimicrobial usage in cancer patients , 2015, Antimicrobial Resistance and Infection Control.

[15]  I. James,et al.  Improving the Effectiveness of Penicillin Allergy De-labeling. , 2015, The journal of allergy and clinical immunology. In practice.

[16]  A. Gervaix,et al.  The role of penicillin in benign skin rashes in childhood: A prospective study based on drug rechallenge , 2010, Journal of Allergy and Clinical Immunology.